Federal grants to The University of Texas Health Science Center at Tyler
The University of Texas Health Science Center at Tyler in Tyler, Texas received $43.0 million in federal grants from fiscal 2021 to 2025, across 46 awards. Its largest program was Cardiovascular Diseases Research, with $16.5 million. In fiscal 2025 it was awarded $7.4 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$43.0 million
- Awards46
- Awarded in FY 2025$7.4 million
- Largest award$7.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 21 | $9.5 million |
| FY 2022 | 21 | $10.9 million |
| FY 2023 | 16 | $6.2 million |
| FY 2024 | 21 | $8.9 million |
| FY 2025 | 17 | $7.4 million |
Programs that fund The University of Texas Health Science Center at Tyler
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 16 | $16.5 million |
| Occupational Safety and Health Program | 2 | $8.8 million |
| Allergy and Infectious Diseases Research | 8 | $4.2 million |
| Tuberculosis Demonstration, Research, Public and Professional Education | 1 | $2.6 million |
| Telehealth Programs | 2 | $1.6 million |
| Epidemiology and Other Health Studies Financial Assistance Program | 1 | $1.5 million |
| Graduate Psychology Education | 1 | $1.2 million |
| Biomedical Research and Research Training | 1 | $1.1 million |
| Military Medical Research and Development | 2 | $1.0 million |
| Child Health and Human Development Extramural Research | 1 | $918,678 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 40 | $40.2 million |
| Department of Energy | 1 | $1.5 million |
| Department of Defense | 2 | $1.0 million |
| National Science Foundation | 1 | $200,000 |
| Department of Education | 2 | $30,115 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Southwest center for agricultural health, injury prevention, and education | Occupational Safety and Health Program | October 15, 2020 | $7.6 million |
| Heartland national tb center, tb centers of excellence for training, education, and medical consultation (tb coe) | Tuberculosis Demonstration, Research, Public and Professional Education | December 14, 2020 | $2.6 million |
| Enhanced delivery of thrombolytic carriers for empyema - project summary empyema (EMP) is increasing in frequency worldwide and is associated with a mortality rate of up to 20% in patients older than 65 years. Thoracic surgery for treating emp is invasive and many patients have co-morbidities that p | Cardiovascular Diseases Research | July 14, 2021 | $2.5 million |
| Delivery of PAI-1-TARGETED intrapleural fibrinolytic therapy for empyema | Cardiovascular Diseases Research | March 11, 2021 | $2.1 million |
| Development, formulation and inhalational delivery of a new peptide for ild - interstitial lung diseases (ILDS) are characterized by progressive pulmonary scarring. Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of ilds and is a fatal lung disease with an incidence of 60 cases/1 | Cardiovascular Diseases Research | December 11, 2020 | $1.8 million |
| Pantex former worker medical surveillance program | Epidemiology and Other Health Studies Financial Assistance Program | January 29, 2021 | $1.5 million |
| Membrane phospholipids: the key regulator of tissue factor encryption/decryption | Cardiovascular Diseases Research | October 19, 2020 | $1.4 million |
| Factor viia-released extracellular vesicles: their role in hemostasis and beyond - clotting factor viia (FVIIA) initiates the activation of the coagulation cascade by binding to the procoagulant cofactor tissue factor. Recombinant fviia is a clinically approved drug for treating bleeding in hemophil | Cardiovascular Diseases Research | March 8, 2024 | $1.4 million |
| Innovative training experiences for occupational medicine residents in non-urban and agricultural settings | Occupational Safety and Health Program | January 26, 2021 | $1.2 million |
| The role of GAB2-MALT1-MEDIATED cell signaling in venous thrombogenesis - venous thromboembolism (VTE), which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of vascular death after a heart attack and stroke. Vte is responsible for 300 000 deaths annu | Cardiovascular Diseases Research | July 15, 2024 | $1.2 million |
Questions people ask
How much federal grant money does The University of Texas Health Science Center at Tyler get?
$43.0 million in 46 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The University of Texas Health Science Center at Tyler the most?
The Department of Health and Human Services, with $40.2 million in 40 awards. The Department of Energy and the Department of Defense follow.
What is The University of Texas Health Science Center at Tyler's largest federal grant?
$7.6 million under Occupational Safety and Health Program, with its first action in the period on October 15, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The University of Texas Health Science Center at Tyler?
Its largest are Cardiovascular Diseases Research, Occupational Safety and Health Program and Allergy and Infectious Diseases Research.
Other grant recipients in Tyler
- Tyler Junior College
- The University of Texas at Tyler
- Texas College
- City of Tyler
- Tyler Family Circle of Care
- City of Tyler
- Tyler Independent School District
- City of Tyler
Largest federal grant recipients in Texas · Federal grants in Texas